● Recruiting

Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders

Condition: Dementia · Major Neurocognitive Disorder · Sponsor: HAII corp.ltd

PhaseNA

Planned participants122

Who can joinAll sexes, 55 Years to 85 Years

Healthy volunteersNo

About this study

The goal of this clinical trial is to evalute the efficacy of ALZGUARD, a smartphone-based digital therapeutic(DTx), in comparison to diagnosis by medical doctors, as weel as to assess the safety of the application.

This description comes directly from the study's public registry record.

Talk to the study team

Rachel Lee · +82 10-7390-5023 · rachel.lee@haii.io

Always discuss trial participation with your own doctor first.

Locations (3)

Kangwon National University Hospital	Chuncheon, Gangwon-do, South Korea	Recruiting
Ewha Womans University Mokdong Medical Center	Seoul, South Korea	Recruiting
Yongin Severance Hospital	Seoul, South Korea	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06615167